Abstract
Following marrow transplantation in both patients and animals, cells containing donor nuclei have been detected in a variety of nonhematopoietic tissue. Whether this phenomenon represents transdifferentiation of marrow-derived cells, infiltration of blood cells, or cell fusion is still controversial. In muscle, where cell fusion occurs during normal myogenesis, fusion of marrow-derived cells with resident myotubes is a likely explanation. We tested eight subpopulations of human bone marrow for their ability to fuse with mouse C2C12 myoblast cells. Relatively high fusion efficiency was observed with marrow stromal cells whereas hematopoietic cells, including populations enriched for stem cells, progenitor cells and monocytes were refractory to fusion. Mouse myotubes containing human nuclei also contained transcripts for human muscle specific genes.
Injection in vivo of human stromal cells expressing green fluorescent protein (GFP) into
the regenerating tibialis anterior muscle of NOD/SCID β2m-/-mice resulted in regenerating mouse muscle fibers expressing GFP. These data suggest that marrowderived cells contribute to myogenesis through fusion and that stromal cells are better fusion partners than hematopoietic cells.
Introduction
Recent reports suggest that bone marrow derived cells can be detected in regenerated muscle tissue of mice [1] [2] [3] [4] . In addition, bone marrow transplantation in the mdx mouse, a model for Duchenne muscular dystrophy (DMD), resulted in the detection of donor cellderived dystrophin in affected muscle fibers 5, 6 . The presence of donor cells in muscle fibers was also observed in a DMD patient who received an allogeneic marrow transplantation at one year of age 7 . However in both the mdx mouse and the DMD patient the contribution of donor cells to affected muscle was very low and did not impact muscle function 7, 8 . Whether this low frequency event represents transdifferentiation of marrow stem cells into muscle or rare fusion events remains controversial [9] [10] [11] .
Resolving this controversy is critical for understanding the real potential and limitations of marrow transplantation. In addition, understanding how marrow cells contribute, even as rare events, to myogenesis is an important step towards developing strategies to increase the frequency of these events. We hypothesized that, regardless of the mechanism, bone marrow derived cells could be therapeutically valuable if a higher frequency of donor cell contribution to myogenesis could be achieved. This concept is supported by studies in which wild-type mesoangioblast cells were shown to rescue the α-sarcoglycan null dystrophic mice through myogenic fusion 12 . To identify human marrow cells with myogenic fusion potential we investigated the ability of human cells to contribute to myogenesis using first a xenogeneic in vitro model combining mouse C2C12 myoblasts with various subsets of human marrow cells, and second using an in vivo regeneration model.
C2C12 cells represent an early stage of muscle differentiation. Depending on the culture conditions, they can either proliferate as myoblasts or differentiate into myotubes 13 .
Previous studies have shown that co-culturing C2C12 cells with dermal fibroblasts resulted in cell fusion and the subsequent correction of the dysgenic membrane in regenerating muscle [14] [15] [16] . The myogenic potential of neural stem cells was also demonstrated by coculture with C2C12 cells 17, 18 . In this report we co-cultured human only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From hematopoietic and non-hematopoietic bone marrow cells with C2C12 and found that stromal cells have a significantly greater potential to contribute to myotube formation than enriched populations of hematopoietic progenitor cells, and that this contribution is due to cell fusion. Human stromal cells also contributed to regenerating muscle in vivo in the NOD/SCID β2m-/-mouse.
Material and Methods
Human cell preparations. Human CD34+ cells from cadaveric marrow were provided by the Cellular Therapy Laboratory, Fred Hutchinson Cancer Research Center. Flow sorting was used to prepare CD34+ and CD34+/38-populations, both greater than 95% pure. A more differentiated CD33+ population was expanded from the CD34+ cells by culturing for 6 days in RPMI with 10 ng/ml IL-3, IL-6, G-CSF, and SCF. More mature CD14+ cells were sorted from peripheral blood mononuclear cells obtained from healthy donors. Long term marrow cultures (LTC) and mesenchymal stem cells (MSC) were prepared from normal donor marrow as described previously 19, 20 . Both the LTC and MSC populations were depleted of CD45+ cells prior to co-culturing with C2C12 myoblasts. and RT-PCR were performed using superscript one step RT-PCR system (Invitrogen) with human specific MYH-2 primers (forward, 5'-ctgctgaaggagagggagct-3'; reverse, 5'-tgattagctggtcacacctt-3') and actin primers (forward, 5'-agagctacgagctgcctgacggcc-3'; reverse, 5'-agtgatctccttctgcatcctgtcc-3'). The PCR products were resolved by electrophoresis on a 1.5 % agarose gel and visualized by ethidium bromide staining. Fig 1A) . Human nuclei are unequivocally identified by staining with an anti-human nuclei monoclonal antibody (Fig 1B) , while the numerous mouse nuclei present in this field as shown by DAPI staining (Fig 1D) are negative. The contribution of human marrow cells to the myotubes was determined by the presence of human nuclei in the myotubes, which were easily distinguished from those outside the myotubes by spatial correlation of human nuclei staining with nuclear spaces revealed by MF20 staining (Fig 1A and 1C) .
The results in Figure 1 showed that co-culture of human LTC cells with the C2C12 mouse myoblasts resulted in the contribution of human nuclei to mouse myotubes. The Triple staining to identify cell fusion. 5,000 human marrow cells from a long-term culture were co-cultured with 5,000 C2C12 cells for 4 days under conditions that favored proliferation. The cultures were then switched to differentiation media for 2 days to induce myogenic fusion. Myotubes were revealed by sarcomeric myosin heavy chain monoclonal antibody MF20 (A). Human nuclei were detected by antibody specific to human nuclei (B). The fusion of human marrow cells (arrow head) with myotubes was detected by correlating the human nuclei with nuclear spaces in the myotube (C). In contrast, unfused stromal cells (arrow) did not align with the myotube nuclear space. Total cell nuclei in the culture were stained with DAPI (D, blue). The same results were observed from CD45 depleted primary stromal cells and mesenchymal stem cells. However, human stromal cell lines HS-5 (E) and HS-27a (F) failed to fuse with C2C12 in co-culture.
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Recently mesenchymal stem cells (MSC) from marrow were reported to give rise to adipocytes, chondrocytes, osteocytes, and stromal cells under different culture conditions [20] [21] [22] . Given their pleiotropic potential, we tested the ability of MSC to fuse with C2C12.
Though the stromal cells generated in LTC media and MSC media are morphologically different and MSC cells proliferated more than LTC cells, a similar number of fusion events were observed (Table 1) . To determine whether fusion was a common feature of adherent stromal cells we tested two immortalized stromal cell lines derived from human LTC. One line, designated HS-5, has small fibroblast like cells that secrete many cytokines. The other, HS-27A, has large cells that support cobble-stone area formation 23, 24 . Both HS-5 and HS-27A failed to fuse with myotubes (Fig 1E and F) , suggesting that only specific subpopulations of marrow stromal cells have the potential to fuse. only.
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Given that both LTC and MSC populations are reported to have stem cell potential, we considered whether the C2C12 co-culture conditions actually induced myogenic differentiation of these cells rather than cell fusion. We hypothesized that fusion would require cell-cell contact whereas 'transdifferentiation' would not. To address this the MSC and C2C12 were initially cultured separately, then added together when myogenic fusion was induced. After two days, no human nuclei containing myotubes were observed. In a separate set of experiments we tested whether C2C12 can induce a myogenic program in MSC through secreted molecules. In this case MSC and C2C12
were cultured in transwells to avoid direct cell-cell contact but allow an exchange of culture media throughout the 6 days of culture. No myosin heavy chain positive staining cells or myotubes were observed in the MSC culture, while normal myogenesis occurred in the chamber containing the C2C12 (data not shown). Therefore, stromal contribution to myotubes requires contact with C2C12 myoblasts.
Lack of myogenic fusion with hematopoietic cells. We next assessed the ability of various hematopoietic cells to fuse with C2C12. Four populations of hematopoietic cells
were studied: CD34+CD38-population that is enriched for stem cells, CD34+ population containing hematopoietic progenitor cells, CD33+ relatively mature myeloid progenitor cells, and CD14+ monocytes. In these experiments 250,000 cells of each type were cocultured with C2C12, and only one myogenic fusion event was detected. These studies are summarized in Table 1 . These negative results raised the concern that the C2C12 culture conditions may adversely affect hematopoietic cells and thereby prevent their fusion. To address this concern we repeated the experiments using LTC media to support hematopoietic cells during the first 4 days of culture. Under these conditions myotube formation still occurred and more human cells were retained, however there were no detectable fusion events (data not shown). Therefore we conclude that hematopoietic cells are refractory to myogenic fusion. myotubes" were positive for multiple human nuclei. However the staining intensity of these nuclei was not consistent, but rather appeared as a decreasing gradient from one brightly stained nucleus. This observation suggested that the human nuclear proteins from one nucleus were transported to neighboring mouse nuclei. Transportation of proteins among nuclei in myotubes has been described previously 15 . We hypothesized that mouse muscle-specific transcription factors may translocate in a similar fashion to human nuclei and turn on transcription of human muscle-specific genes. To measure the human muscle gene expression, total RNA was isolated from C2C12, LTC, MSC, and co-cultures of LTC and MSC with C2C12. RT-PCR was performed using human specific primers.
Among several myosin heavy chain genes tested, we detected elevated myosin heavy chain IIa gene expression in the co-cultures, indicating that muscle specific genes in stromal cell can be turned on through myogenic fusion (Fig 2) . In comparison to uniform staining of the intact human nuclei shown in Figure 1 , the staining of the nucleus in 3B has a stippled pattern due to the fact that this image represents a section through the nucleus. The TA muscle of the NOD/SCID β2m-/-mouse was damaged by cardiotoxin injection followed 24 hours later by injection of MSC . The regenerating TA muscles were evaluated seven days later. Immunoflorescence staining of regenerating TA muscle showed the presence of human nuclei in muscle fibers; A) Red rhodamine phalloidin staining of mouse TA muscle with blue DAPI nuclear staining; B) Human nuclear staining (green) with anti-human nuclear antibody; C) composite of A and B. H&E staining of a frozen section of regenerating TA muscle (D) and fluorescence microscopy of the same section showing a GFP expressing fiber (E). Two GFP+ fibers, each longer than 100um, are shown in a snapshot of a 3D projection of a stack of 44 green and red two-channel images of a regenerating TA muscle (F) . A rotating video of this section is available as supplemental data.
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To verify the fusion of human MSC cells with mouse muscle, GFP expressing MSC were prepared by lentiviral infection. The GFP positive MSC cells were then injected into the regenerating TA muscle. After a week, the TA muscles were examined for the presence of green fibers. No GFP signals were observed in PBS-injected control TA muscle.
However GFP positive fibers were present in GFP-MSC injected muscle (Fig 3D) .
Hematoxylin and eosin staining of the same section suggested that the GFP signals originated from regenerating TA myofibers but were absent in undamaged muscles (arrows, Fig 3D and E) . The presence of GFP+ myofibers was confirmed by confocal microscopy ( Fig 3F and supplemental data) . In these experiments more than 100 6µm longitudinal sections were cut per TA muscle, and one section per every 20 sections was analyzed for GFP expressing fibers. The average number of myotubes per section was 4,396 and had on average one GFP+ fiber. These data indicate that 0.023% of total TA muscle fibers were GFP+.
Discussion
The detection of bone marrow derived cells in muscle as well as many other tissues has generated considerable enthusiasm for rethinking the differentiative potential of adult stem cells and their possible role for various tissue replacement therapies. Though there are multiple reports of marrow-derived cells in non-hematopoietic tissue, the significance of the findings remains unclear due to the low frequency of these events, as does an understanding of the mechanism responsible for the observation.
In bone marrow transplant recipients, donor blood cells will be present in every tissue in the body. Therefore, when searching for donor cell contribution to recipient tissue care must be taken to control for blood derived lymphocytes and macrophages. This is a particular issue for in vivo experiments in which tissue damage is used to trigger regeneration, resulting in recruitment of blood, ultimately marrow-derived cells to the damaged area. Donor cell contribution to regeneration can, at least theoretically, take several forms: macrophages can scavenge dead cells and secrete factors that favor endogenous regeneration, lymphocytes may also produce beneficial factors, totipotent In the current study, we first used differentiating mouse C2C12 myoblasts as an in vitro model of myogenesis to test the capability of different human bone marrow cells to fuse with myotubes. We found that marrow stromal cells cultured either as LTC or MSC, but not hematopoietic cells, fuse with C2C12 myoblasts. The fusion required cell-cell contact, and resulted in the expression of human myosin heavy chain.
We tested four populations of human cells in the hematopoietic lineage, CD34+CD38-an enriched stem cell population, CD34+ enriched for stem/ progenitor cells, CD33+ committed myeloid progenitor cells, and CD14+ monocytes. With the exception of one rare event, these cells were not able to fuse with C2C12 cells and contribute to myotubes.
The one exception was in the CD34+ cell population which could, at least theoretically, be attributed to stromal precursors known to express CD34 25 . The lack of hematopoietic fusion with C2C12 was not due to the culture conditions: experiments were also conducted using culture media that supported the survival of hematopoietic cells, yet no fusion occurred between hematopoietic cells and myotubes. Our failure to demonstrate a contribution of hematopoietic cells to myogenesis in vitro is consistent with recent publications that showed only rare hematopoietic cell contribution to myogenesis in vivo, in both the cardio toxin injury and mdx mouse models 26, 27 . These reports question the efficacy of hematopoietic stem cell transplantation for the treatment of muscle diseases.
The non-hematopoietic cells in the marrow, or stromal cells, are a heterogenous population. They provide the microenvironmental (ME) niche for stem cells and their progeny. The ME can be approximated in vitro in primary long-term cultures (LTC)
established from marrow aspirates. More recent studies have described culture conditions that allow the outgrowth of stromal cells reported to have stem cell potential. These are termed mesenchymal stem cells (MSC). In our C2C12 fusion study, cells from both LTC only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From and MSC cultures were able to fuse with C2C12. In addition, an increased level of human myosin heavy chain expression in the C2C12 co-cultures indicated that both LTC and MSC were able to initiate a myogenic program. Importantly, immortalized human stromal cell lines, HS5 and HS27a failed to fuse with C2C12, suggesting that fusion was not necessarily promiscuous among adherent, fibroblastic cells. Although fusion of fibroblasts with myogenic cells in vitro has been reported previously 15, 16 , and may suggest little in the way of specificity for fusion partners, our results suggest otherwise.
We tested nine populations of human cells and found significant differences among them in terms of fusion frequencies (Table 1 Whether such fusion events could eventually prove therapeutic is unclear. Much work is needed to establish the in vivo relevance of this observation; paramount among this work is the development of ways to deliver therapeutic cell preparations to target tissue and to increase the frequency of the fusion events. Understanding the molecular mechanisms involved in stroma/C2C12 fusion in vitro could provide insights needed to increase the fusion efficiency in vivo.
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